» Articles » PMID: 37821504

H19 Encourages Aerobic Glycolysis and Cell Growth in Gastric Cancer Cells Through the Axis of MicroRNA-19a-3p and Phosphoglycerate Kinase 1

Overview
Journal Sci Rep
Specialty Science
Date 2023 Oct 11
PMID 37821504
Authors
Affiliations
Soon will be listed here.
Abstract

Numerous studies have been conducted on long non-coding RNAs (lncRNAs) in human tumors like gastric cancer (GC). Our research uncovers how aerobic glycolysis and cell proliferation in gastric cancer cells are related to H19. We discovered that H19 was highly expressed in tumor tissues and that patients with higher H19 expression have a poorer prognosis. Intriguingly, we applied the subcellular isolation, luciferase reporter, western blot analysis, MTT, colony formation experiments, and CDX Model in Mice to verify that H19 regulates aerobic glycolysis towards GC cell growth by H19/microRNA (miR)-19a-3p/phosphoglycerate kinase 1 (PGK1) axis. Together, our research offers proof that the H19/miR-19a-3p/PGK1 pathway aids in the regulation of aerobic glycolysis and cell proliferation in GC. This may offer an opportunity for novel therapeutic approaches to the treatment of GC.

Citing Articles

Delactylase effects of SIRT1 on a positive feedback loop involving the H19-glycolysis-histone lactylation in gastric cancer.

Tsukihara S, Akiyama Y, Shimada S, Hatano M, Igarashi Y, Taniai T Oncogene. 2024; 44(11):724-738.

PMID: 39658647 DOI: 10.1038/s41388-024-03243-6.


RNA Binding Protein PTBP1 Promotes the Metastasis of Gastric Cancer by Stabilizing mRNA.

Wang X, Liang C, Wang S, Ma Q, Pan X, Ran A Cells. 2024; 13(2).

PMID: 38247832 PMC: 10814388. DOI: 10.3390/cells13020140.

References
1.
Fang Z, Wang Y, Wang Z, Xu M, Ren S, Yang D . Is an Estrogen-Responsive LncRNA That Drives Breast Cancer through the E2F1/RB1 Pathway. Cancer Res. 2020; 80(20):4399-4413. PMC: 7572695. DOI: 10.1158/0008-5472.CAN-20-1031. View

2.
Gandhi M, Gross M, Holler J, Coggins S, Patil N, Leupold J . The lncRNA lincNMR regulates nucleotide metabolism via a YBX1 - RRM2 axis in cancer. Nat Commun. 2020; 11(1):3214. PMC: 7316977. DOI: 10.1038/s41467-020-17007-9. View

3.
Zhang H, Zhu C, He Z, Chen S, Li L, Sun C . LncRNA PSMB8-AS1 contributes to pancreatic cancer progression via modulating miR-382-3p/STAT1/PD-L1 axis. J Exp Clin Cancer Res. 2020; 39(1):179. PMC: 7487636. DOI: 10.1186/s13046-020-01687-8. View

4.
Zhang M, Wang N, Song P, Fu Y, Ren Y, Li Z . LncRNA GATA3-AS1 facilitates tumour progression and immune escape in triple-negative breast cancer through destabilization of GATA3 but stabilization of PD-L1. Cell Prolif. 2020; 53(9):e12855. PMC: 7507373. DOI: 10.1111/cpr.12855. View

5.
Lecerf C, Le Bourhis X, Adriaenssens E . The long non-coding RNA H19: an active player with multiple facets to sustain the hallmarks of cancer. Cell Mol Life Sci. 2019; 76(23):4673-4687. PMC: 11105575. DOI: 10.1007/s00018-019-03240-z. View